Optimal dose of brexpiprazole for augmentation therapy of antidepressant‐refractory depression: A systematic review and dose‐effect meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimal dose of brexpiprazole for augmentation therapy of antidepressant‐refractory depression: A systematic review and dose‐effect meta‐analysis

Published:2022-07-12 Issue:9 Volume:76 Page:416-422
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

Furukawa Yuki¹²^ORCID,Oguro Saki¹,Obata Satomi¹,Hamza Tasnim³,Ostinelli Edoardo G.⁴⁵⁶,Kasai Kiyoto¹^ORCID

Affiliation:

1. Department of Neuropsychiatry University of Tokyo Hospital Tokyo Japan

2. Tokyo Musashino Hospital Tokyo Japan

3. Institute of Social and Preventive Medicine University of Bern Bern Switzerland

4. Department of Psychiatry University of Oxford Oxford UK

5. Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre Oxford UK

6. Oxford Health NHS Foundation Trust, Warneford Hospital Oxford UK

Funder

Shionogi

Ono Pharmaceutical

Eisai

Mitsubishi Tanabe Pharma Corporation

Eli Lilly Japan

Novartis

Dainippon Sumitomo Pharma

Otsuka Pharmaceutical

National Institute for Health Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13438

Reference46 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

2. A network meta‐analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression

3. Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis

4. Trends in Outpatient Psychotherapy Provision by U.S. Psychiatrists: 1996–2016

5. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole;Neuropsychopharmacology;2024-08-15

2. A psychometric analysis of the Japanese version of the clinically useful depression outcome scale supplemented with questions for the DSM‐5 anxious distress specifier (CUDOS‐A);Neuropsychopharmacology Reports;2024-06-05

3. Comparative Efficacy of Dopamine Partial Agonists by Doses for Treatment-Resistant Depression;Journal of Clinical Psychopharmacology;2024-04-19

4. Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double‐blind (BLESS) study;Psychiatry and Clinical Neurosciences;2023-12

5. Explaining How Psychotherapy Affects the Brain Can Increase the Perceived Effectiveness of Psychotherapy: A Randomized Controlled Trial;Behavior Therapy;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3